Corcept’s Phase 2 Trial of Dazucorilant Shows Sustained Two-Year Survival Advantage in ALS Patients Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on developing therapies that modulate cortisol…
Curocell’s RIMQARTO Injection Secures Full Regulatory Approval, Positioned to Enter CAR-T Market with 67% Complete Response Rate South Korean biotechnology company Curocell (KOSDAQ: 372320) has achieved a landmark milestone in…
TRexBio Initiates Phase 1b Study of TRB-061 in Moderate-to-Severe Atopic Dermatitis with First Patient Dosed TRex Bio, Inc. (“TRexBio”), a clinical-stage biotechnology company focused on discovering and developing immunoregulatory therapies…
U.S. FDA Accepts Priority Review for Gilead’s Once-Daily HIV Therapy Combining Bictegravir and Lenacapavir Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted its New…
Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer Convergent Therapeutics, a clinical-stage biotech company dedicated to advancing next-generation radiopharmaceutical therapies for cancer, has announced the appointment of…
Cosette Pharmaceuticals Names Erika Tooman as Senior Vice President and General Counsel, Enhancing Leadership to Support Growth and Strategic Expansion Cosette Pharmaceuticals, a U.S.-based branded specialty pharmaceutical company, has announced…
ClearNote Health to Showcase Leading Early Detection Results for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026 ClearNote Health, a biotechnology company focused on advancing early cancer detection, has…
Ansa Biotechnologies to Highlight Next-Generation DNA Synthesis Innovation with Industry-Exclusive On-Time Delivery Guarantee at SynBioBeta 2026 Ansa Biotechnologies, a biotechnology firm specializing in next-generation DNA synthesis solutions, has announced its…
Strand Therapeutics Names Kunal Bhatia as Chief Financial Officer Strand Therapeutics, a clinical-stage biotechnology company focused on advancing programmable mRNA medicines, has announced the appointment of Kunal Bhatia as its…
Study Reveals Growing Public Optimism for Scientific Breakthroughs Amid Increasing Concerns Over the Pace of Global Change A new global report developed by Leaps by Bayer in collaboration with Boston…
Ray Therapeutics Secures PRIME Designation from the European Medicines Agency for RTx-015 Targeting Retinitis Pigmentosa Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company focused on developing innovative therapies for vision restoration,…
Masimo SET® Pulse Oximetry Demonstrates Consistent Accuracy Across All Newborn Skin Tones in Largest-Ever Real-World Prospective Study Masimo has announced new clinical findings that reinforce the accuracy and reliability of…